Comparative effectiveness board named
This article was originally published in The Gray Sheet
Executive Summary
The device sector is represented by two of the three medical product industry executives appointed to the board of governors for the new Patient-Centered Outcomes Research Institute, which was established by health care reform to direct federal comparative effectiveness research efforts. On Sept. 23, the Government Accountability Office announced its 19 selections to join two HHS officials on the board. Harlan Weisman, chief science and technology officer for Johnson & Johnson Medical Devices and Diagnostics, will serve a six-year term. Richard E. Kuntz, senior VP and chief scientific, clinical and regulatory officer for Medtronic, will sit on the board through September 2012. The drug industry is represented by a Pfizer executive. The board will be chaired by Eugene Washington, dean of the University of California, Los Angeles Medical School